| Ident. | Authors (with country if any) | Title |
|---|
| 000032 (2014) |
Philip G. Conaghan [Royaume-Uni, Nouvelle-Zélande, Australie, États-Unis, Norvège, France, Israël, Danemark, Allemagne] ; Fiona M. Mcqueen ; Paul Bird ; Charles Peterfy ; Espen Haavardsholm ; Frédérique Gandjbakhch ; Iris Eshed ; Ida K. Haugen ; Siri Lillegraven ; Uffe M Ller D Hn ; Bo Ejbjerg ; Violaine Foltz ; Laura Coates ; Pernille B Yesen ; Kay-Geert Hermann ; Jane Freeston ; Marissa Lassere ; Philip O'Connor ; Paul Emery ; Harry Genant ; Mikkel Stergaard | Update on the OMERACT Magnetic Resonance Imaging Task Force: Research and Future Directions |
| 000200 (2014) |
Jacob L. Jaremko [Canada, Suisse, France, Allemagne, États-Unis, Australie, Irlande (pays), Royaume-Uni, Danemark] ; Robert G. W. Lambert ; Veronika Zubler ; Ulrich Weber ; Damien Loeuille ; Frank W. Roemer ; Jolanda Cibere ; Marcus Pianta ; David Gracey ; Philip Conaghan ; Mikkel Ostergaard ; Walter P. Maksymowych | Methodologies for Semiquantitative Evaluation of Hip Osteoarthritis by Magnetic Resonance Imaging: Approaches Based on the Whole Organ and Focused on Active Lesions |
| 000218 (2014) |
Ida K. Haugen [Norvège, Danemark, Israël, Nouvelle-Zélande, Australie, France, États-Unis, Royaume-Uni] ; Mikkel Stergaard ; Iris Eshed ; Fiona M. Mcqueen ; Paul Bird ; Frederique Gandjbakhch ; Violaine Foltz ; Harry Genant ; Charles Peterfy ; Siri Lillegraven ; Espen A. Haavardsholm ; Pemille B Yesen ; Philip G. Conaghan | Iterative Development and Reliability of the OMERACT Hand Osteoarthritis MRI Scoring System |
| 000603 (2013) |
M. Hochberg [États-Unis] ; X. Chevalier [France] ; Y. Henrotin [Belgique] ; D. J. Hunter [Australie] ; D. Uebelhart [Suisse] | Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what's the evidence? |
| 000998 (2013) |
Jean-Yves Reginster [Belgique] ; Janusz Badurski [Pologne] ; Nicholas Bellamy [Australie] ; William Bensen [Canada] ; Roland Chapurlat [France] ; Xavier Chevalier [France] ; Claus Christiansen [Danemark] ; Harry Genant [États-Unis] ; Federico Navarro [Espagne] ; Evgeny Nasonov [Russie] ; Philip N. Sambrook [Australie] ; Timothy D. Spector [Royaume-Uni] ; Cyrus Cooper [Royaume-Uni] | Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial |
| 000F47 (2012) |
F. Tubach [France] ; P. Ravaud [France] ; E. Martin-Mola [Espagne] ; H. Awada [Liban] ; N. Bellamy [Australie] ; C. Bombardier [Canada] ; D. T. Felson [États-Unis] ; N. Hajjaj-Hassouni [Maroc] ; M. Hochberg [États-Unis] ; I. Logeart [France] ; M. Matucci-Cerinic [Italie] ; M. Van De Laar [Pays-Bas] ; D. Van Der Heijde [Pays-Bas] ; M. Dougados [France] | Minimum Clinically Important Improvement and Patient Acceptable Symptom State in Pain and Function in Rheumatoid Arthritis, Ankylosing Spondylitis, Chronic Back Pain, Hand Osteoarthritis, and Hip and Knee Osteoarthritis: Results From a Prospective Multinational Study |
| 001009 (2012) |
Vincentt. Carpentier [Australie, France] ; Jinquan Wong [Australie] ; Youwen Yeap [Australie] ; Cheryl Gan [Australie] ; Peter Sutton-Smith [Australie] ; Arash Badiei [Australie] ; Nicola L. Fazzalari [Australie] ; Julia S. Kuliwaba [Australie] | Increased proportion of hypermineralized osteocyte lacunae in osteoporotic and osteoarthritic human trabecular bone: Implications for bone remodeling |
| 001705 (2011) |
Gilles Walch [France] ; Allan A. Young [Australie] ; Barbara Melis [France] ; Dominique Gazielly [Suisse] ; Markus Loew [Allemagne] ; Pascal Boileau [France] | Results of a convex-back cemented keeled glenoid component in primary osteoarthritis: multicenter study with a follow-up greater than 5 years |
| 001725 (2011) |
Cornelia M. Borkhoff [Canada] ; Mark L. Wieland [États-Unis] ; Elena Myasoedova [États-Unis] ; Zareen Ahmad [Canada] ; Vivian Welch [Canada] ; Gillian A. Hawker [Canada] ; Linda C. Li [Canada] ; Rachelle Buchbinder [Australie] ; Erin Ueffing [Canada] ; Dorcas Beaton [Canada] ; Mario H. Cardiel [Mexique] ; Sherine E. Gabriel [États-Unis] ; Francis Guillemin [France] ; Ade O. Adebajo [Royaume-Uni] ; Claire Bombardier [Canada] ; Najia Hajjaj-Hassouni [Maroc] ; Peter Tugwell [Canada] | Reaching Those Most in Need: A Scoping Review of Interventions to Improve Health Care Quality for Disadvantaged Populations With Osteoarthritis : QUALITY OF CARE IN THE RHEUMATIC DISEASES |
| 001903 (2011) |
Kenneth Tang [Canada, Suisse, Pays-Bas, Royaume-Uni, Australie, France] ; Reuben Escorpizo ; Dorcas E. Beaton ; Claire Bombardier ; Diane Lacaille ; WEI ZHANG ; Aslam H. Anis ; Annelies Boonen ; Suzanne M. M. Verstappen ; Rachelle Buchbinder ; Richard H. Osborne ; Bruno Fautrel ; Monique A. M. Gignac ; Peter S. Tugwell | Measuring the Impact of Arthritis on Worker Productivity: Perspectives, Methodologic Issues, and Contextual Factors |
| 003272 (2008) |
O. Bruyere [Belgique] ; D. Delferriere [Belgique] ; C. Roux [France] ; J. D. Wark [Australie] ; T. Spector [Royaume-Uni] ; J.-P. Devogelaer [Belgique] ; K. Brixen [Danemark] ; S. Adami [Italie] ; J. Fechtenbaum [France] ; S. Kolta [France] ; J.-Y. Reginster [Belgique] | Effects of strontium ranelate on spinal osteoarthritis progression |
| 003733 (2007) |
Laure Gossec [France, Canada, Suède, États-Unis, Royaume-Uni, Australie, République tchèque, Italie] ; Gillian Hawker [France, Canada] ; Aileen M. Davis [Canada] ; Jean Francis Maillefert [France] ; L. Stefan Lohmander ; Roy Altman ; Jolanda Cibere ; Philip G. Conaghan ; Marc C. Hochberg ; Joanne M. Jordan ; Jeffrey N. Katz ; Lyn March ; Nizar Mahomed ; Karel Pavelka ; Ewa M. Roos ; Maria E. Suarez-Almazor ; Gustavo Zanoli ; Maxime Dougados | OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis |
| 004289 (2005) |
F. Tubach [France] ; G. Baron [France] ; B. Falissard [France] ; I. Logeart [France] ; M. Dougados [France] ; N. Bellamy [Australie] ; P. Ravaud [France] | Using patients' and rheumatologists' opinions to specify a short form of the WOMAC function subscale |
| 004617 (2005) |
F. Tubach [France] ; P. Ravaud [France] ; G. Baron [France] ; B. Falissard [France] ; I. Logeart [France] ; N. Bellamy [Australie] ; C. Bombardier [Canada] ; D. Felson [États-Unis] ; M. Hochberg [États-Unis] ; D. Van Der Heijde [Pays-Bas] ; M. Dougados [France] | Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state |
| 004618 (2005) |
F. Tubach [France] ; P. Ravaud [France] ; G. Baron [France] ; B. Falissard [France] ; I. Logeart [France] ; N. Bellamy [Australie] ; C. Bombardier [Canada] ; D. Felson [États-Unis] ; M. Hochberg [États-Unis] ; D. Van Der Heijde [Pays-Bas] ; M. Dougados [France] | Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement |
| 006383 (1998) |
J. Dequeker [Belgique] ; C. Hawkey [Royaume-Uni] ; A. Kahan [France] ; K. Steinbrück [Allemagne] ; C. Alegre [Espagne] ; E. Baumelou [France] ; B. Begaud [France] ; H. Isom Ki [Finlande] ; G. Littlejohn [Australie] ; J. Mau [Allemagne] ; S. Papazoglou [Grèce] | Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam : Results of the safety and efficacy large-scale evaluation of COX-inhibiting therapies (select) trial in osteoarthritis |
| 006405 (1998) |
C. Hawkey [États-Unis] ; A. Kahan [France] ; K. Steinbrück [Allemagne] ; C. Alegre [Espagne] ; E. Baumelou [France] ; B. Begaud [France] ; J. Dequeker [Belgique] ; H. Isom Ki [Finlande] ; G. Littlejohn [Australie] ; J. Mau [Allemagne] ; S. Papazoglou [Grèce] | Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients |
| 006637 (1997) |
N. Bellamy [Canada, Royaume-Uni, Pays-Bas, Australie, États-Unis, France] ; J. Kirwan ; M. Boers ; P. Brooks ; V. Strand ; P. Tugwell ; R. Altman ; K. Brandt ; M. Dougados ; M. Lequesne | Recommendations for a core set of outcome measures for future Phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III |
